So News Corp boss Rupert Murdoch was so keen to meet Education Secretary Michael Gove that he notched up six meetings since the general election and two in the space of 10 days last month... more
Three cheers for GlaxoSmithKline boss Andrew Witty, who says: "I don't buy that you can be this floating entity with no allegiance to anybody but the lowest tax rate." Well said, and say it again to Barclays, reportedly threatening to take its ball and "leave" the country... more
Market round-up: As Flybe, Britain’s biggest regional airline, hit some turbulence on its first official day of trading, George Soros is revealed to be one of the passengers on board... more
Downing Street is extremely proud of its new Business Advisory Group. I don’t want to be a dreadful sceptic but I can’t help it: I feel the need to emit a large yawn... more
So, as Goldman Sachs bids farewell to one of its biggest rainmakers of the past decade — Simon Dingemans, who is joining GlaxoSmithKline — City Spy wonders how confident the Fleet Street investment bank now feels about winning juicy future contracts with the Lib-Cons... more
GlaxoSmithKline stuns the City with the appointment of one of the Square Mile's most famous mergers and acquisitions 'rainmakers' to be its next chief financial officer.... more
GlaxoSmithKline posts a £304 million second-quarter loss after £1.57 billion in costs for settling several legal cases over drugs including diabetes treatment Avandia... more
Analysis: Convenient timing? Just before posting eye-wateringly high profit, GlaxoSmithKline announces plans to slash the cost of medicine to the world's poorest people... more
GlaxoSmithKline, the drug company producing the bulk of Britain’s swine flu vaccine, said third-quarter pre-tax profit soared 23% to £1.91 billion as the firm cashed in from a boost in emerging markets and H1N1 drugs ... more
Pharma giant GlaxoSmith Kline was today given a boost when the World Health Organisation endorsed its vaccine against a diarrhoea-causing virus that kills 500,000 children every year ... more
GlaxoSmithKline has revamped the pay deal for its new chief executive Andrew Witty, who took over last May, following past controversies over remuneration at Europe's biggest drugmaker... more
Analysis: The head of Pfizer, the world's largest drug company, this week set the pharmaceutical industry alight with talk of a megadeal when he revealed a shopping list of rivals in his sights... more
Tonight:
3°c
